|
BCDIN3D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.7785772854495E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.88910007029131E-11 |
| Normal-vs-Stage2 |
1.503520E-03 |
| Normal-vs-Stage3 |
1.18571819029967E-13 |
| Normal-vs-Stage4 |
1.62669877568078E-12 |
| Stage1-vs-Stage2 |
3.659700E-02 |
| Stage1-vs-Stage3 |
2.868400E-02 |
| Stage1-vs-Stage4 |
1.401580E-04 |
| Stage2-vs-Stage3 |
1.043280E-03 |
| Stage2-vs-Stage4 |
7.56290000000215E-05 |
| Stage3-vs-Stage4 |
1.164220E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.90656387846866E-13 |
| Normal-vs-AfricanAmerican |
2.6282999998628E-07 |
| Normal-vs-Asian |
1.47126755223326E-12 |
| Caucasian-vs-AfricanAmerican |
5.222400E-01 |
| Caucasian-vs-Asian |
1.930430E-01 |
| AfricanAmerican-vs-Asian |
9.596800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.94619917140926E-11 |
| Normal-vs-Female |
2.31104024805973E-12 |
| Male-vs-Female |
9.220800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.9611647295601E-12 |
| Normal-vs-Age(41-60Yrs) |
1.58799995375603E-09 |
| Normal-vs-Age(61-80Yrs) |
3.10580450246789E-11 |
| Normal-vs-Age(81-100Yrs) |
1.023670E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.915600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.937200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.458600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.692000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.162800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.082400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.53450005427425E-09 |
| Classical-VS-Follicular |
6.18079999999965E-05 |
| Classical-VS-Other |
5.290000E-01 |
| Classical-VS-Normal |
1.66744396068452E-12 |
| Tall-VS-Follicular |
2.11441975039861E-12 |
| Tall-VS-Other |
1.511380E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
5.319000E-01 |
| Follicular-VS-Normal |
5.751400E-04 |
| Other-VS-Normal |
2.415900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.0239999959083E-08 |
| Normal-vs-N1 |
6.66133814775094E-16 |
| N0-vs-N1 |
1.02379999999958E-06 |
|
|
